Poster 46
- Kelley Tangredi
- May 4, 2024
- 1 min read
Updated: Jun 27, 2024
Deucravacitinib in plaque psoriasis: 4-year safety and efficacy results from the phase 3 POETYK PSO-1, PSO-2, and LTE trials
Authors: April W. Armstrong, Mark Lebwohl, Richard B. Warren, Howard Sofen, Akimchi Morita, Shinichi Imafuku, Mamitaro Ohtsuki, Lynda Spelman, Thierry Passeron, Kim A. Papp, Matthew J. Colombo,John Vaile, Eleni Vritzali, Kim Hoyt, Carolin Daamen, Subhashis Banerjee, Bruce Strober, Diamant Thaçi, Andrew Blauvelt
Poster 46